Literature DB >> 6869370

A case of IgA nephropathy with an unusual response to corticosteroid and immunosuppressive therapy.

K Abreo, S F Wen.   

Abstract

We report a case of IgA nephropathy that presented with nephrotic syndrome without hematuria. Renal biopsy revealed typical features of IgA nephropathy on light microscopy, immunofluorescence microscopy, and electron microscopy. A dramatic response occurred on corticosteroid and immunosuppressive therapy, characterized by clearance of proteinuria and a fall of serum IgA level to normal. The absence of hematuria and a response to therapy are distinctly unusual features of IgA nephropathy. This case represents a variant of IgA nephropathy associated with a nephrotic syndrome that resembles nephrotic syndrome with minimal change lesion in its responsiveness to immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6869370     DOI: 10.1016/s0272-6386(83)80010-9

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  Progression of IgA nephropathy under current therapy regimen in a Chinese population.

Authors:  Xiangling Li; Youxia Liu; Jicheng Lv; Sufang Shi; Lijun Liu; Yuqing Chen; Hong Zhang
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 8.237

2.  Spontaneous remission of nephrotic syndrome in a patient with IgA nephropathy.

Authors:  R J Hogg; D A Savino
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

3.  Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular "immune deposits".

Authors:  R Habib; E Girardin; M F Gagnadoux; N Hinglais; M Levy; M Broyer
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

4.  Clinicopathologic characteristics of IgA nephropathy with steroid-responsive nephrotic syndrome.

Authors:  Sun Moon Kim; Kyung Chul Moon; Kook-Hwan Oh; Kwon Wook Joo; Yon Su Kim; Curie Ahn; Jin Suk Han; Suhnggwon Kim
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.